All articles by Staff Writer

Staff Writer

Top drugs researched for treatment of Asthma

Clinical trials that focus on asthma treatments are pivotal, as there is no long-term effective therapy for the condition.

Amgen and Simcere partner to develop and commercialise biosimilars in China

US-based biotechnology company Amgen has entered an exclusive agreement with Chinese firm Simcere Pharmaceutical Group to co-develop and commercialise four biosimilars in China.

GSK’s Benlysta receives Japanese MHLW approval for systemic lupus erythematosus

GSK’s human monoclonal antibody Benlysta (belimumab) has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to treat adult patients with systemic lupus erythematosus (SLE), a chronic, incurable, autoimmune disease.

EC grants marketing authorisation for Sanofi and Regeneron’s Dupixent for AD

The European Commission (EC) has granted marketing authorisation for Sanofi and Regeneron Pharmaceuticals’ Dupixent (dupilumab) to treat adults with moderate to severe atopic dermatitis (AD), a form of eczema.

US FDA agrees to review Eisai’s application for Lenvima to treat HCC

The US Food and Drug Administration (FDA) has agreed to review Eisai’s application for an additional indication of Lenvima (lenvatinib mesylate) as a first-line treatment for patients with unresectable hepatocellular carcinoma (HCC).